6-gingerol ameliorated doxorubicin-induced cardiotoxicity: Role of nuclear factor kappa B and protein glycation
El-Bakly, W.M.; Louka, M.L.; El-Halawany, A.M.; Schaalan, M.F.;
Abstract
Doxorubicin is a widely used antitumour drug. Cardiotoxicity is considered a major limitation for its clinical use. The present study was designed to assess the possible antioxidant and antiapoptotic effects of 6-gingerol in attenuating doxorubicin-induced cardiac damage.
Other data
| Title | 6-gingerol ameliorated doxorubicin-induced cardiotoxicity: Role of nuclear factor kappa B and protein glycation | Authors | El-Bakly, W.M. ; Louka, M.L. ; El-Halawany, A.M. ; Schaalan, M.F. | Issue Date | 2012 | Journal | Cancer Chemotherapy and Pharmacology | DOI | 6 833-41 http://www.scopus.com/inward/record.url?eid=2-s2.0-84871186031&partnerID=MN8TOARS 70 1432-0843 10.1007/s00280-012-1975-y |
PubMed ID | 23014738 | Scopus ID | 2-s2.0-84871186031 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.